Halozyme Therapeutics Inc (NASDAQ:HALO)

18.48
Delayed Data
As of Feb 20
 -0.06 / -0.32%
Today’s Change
11.41
Today|||52-Week Range
21.13
-8.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash21.6M61.4M43.3M66.8M
 
 
 
 
 
Short Term Investment Cash-72.0M34.0M-18.1M23.5M
 
 
 
 
 
Cash & Short Term Investments71.5M135.6M108.3M205.0M
 
 
 
 
 
 
ReceivablesReceivables9.1M9.1M32.4M15.7M
 
 
 
 
 
 
InventoriesInventories6.2M6.4M9.5M14.6M
 
 
 
 
 
 
Current AssetsOther Current Assets8.4M10.1M21.5M21.2M
 
 
 
 
 
Current Assets95.2M161.3M171.8M256.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross11.1M12.2M14.3M16.2M
 
 
 
 
 
Depreciation-7.6M-9.2M-10.3M-11.9M
 
 
 
 
 
Other Assets2.7M1.2M5.6M219.0K
 
 
 
 
 
Total Assets101.8M166.0M181.8M261.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.1M3.0M4.5M3.6M
 
 
 
 
 
Short Term Debt0.000.0021.9M17.4M
 
 
 
Accrued Expenses7.8M8.0M15.0M17.3M
 
 
 
 
 
Other Current Liabilities15.2M15.4M27.5M22.1M
 
 
 
 
 
Other Liabilities25.5M24.3M62.5M54.6M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt49.8M49.9M28.0M199.2M
 
 
 
 
 
Other Liabilities18.3K3.2M4.4M358.0K
 
 
 
 
 
Total Liabilities121.8M124.6M138.8M294.0M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-20.0M41.4M43.0M-32.5M
 
 
 
 
 
Total Shareholder Equity-20.0M41.4M43.0M-32.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding114.5M125.7M128.2M129.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.